Heights (Pharmaceuticals) Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 94

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 20

Heights (Pharmaceuticals) General Information

Description

Producer of smart supplements intended to elevate and extend cognitive performance by nourishing the brain. The company's smart supplement focuses on giving the brain the fuel it needs to improve its health performance and mental well-being, enabling customers to get the nourishment they require according to neuroscience and optimize human potential.

Contact Information

Formerly Known As
Grabble, Mobula
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 27 Old Gloucester Street
  • London WC1N 3AX
  • England, United Kingdom
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Vertical(s)
LOHAS & Wellness, E-Commerce
Corporate Office
  • 27 Old Gloucester Street
  • London WC1N 3AX
  • England, United Kingdom

Heights (Pharmaceuticals) Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Heights (Pharmaceuticals) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Secondary Transaction - Private Completed Generating Revenue
12. Secondary Transaction - Private 01-Jan-2023 Completed Generating Revenue
11. Later Stage VC 01-Oct-2022 Completed Generating Revenue
10. Later Stage VC 20-Dec-2021 Completed Generating Revenue
9. Later Stage VC 28-Jan-2021 Completed Generating Revenue
8. Grant 01-Oct-2020 Completed Generating Revenue
7. Later Stage VC 13-Feb-2018 Completed Generating Revenue
6. Accelerator/Incubator 05-Dec-2017 Completed Generating Revenue
5. Early Stage VC 03-Aug-2017 $1.53M $5.17M Completed Generating Revenue
4. Early Stage VC 14-Nov-2016 $1.88M $3.64M Completed Generating Revenue
To view Heights (Pharmaceuticals)’s complete valuation and funding history, request access »

Heights (Pharmaceuticals) Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 135,912 $0.000113 $4.17 $4.17 1x $4.17 1.07%
Ordinary 155,918 $0.000113 $6.17 $6.17 1x $6.17 1.23%
To view Heights (Pharmaceuticals)’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Heights (Pharmaceuticals) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Heights (Pharmaceuticals) Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
ForGood Global Impact Investing Minority
Downing Ventures Venture Capital Minority
Low Carbon Innovation Fund Venture Capital Minority
Spacestation Investments Angel Group Minority
Chris Smalling Angel (individual) Minority
You’re viewing 5 of 20 investors. Get the full list »

Heights (Pharmaceuticals) FAQs

  • When was Heights (Pharmaceuticals) founded?

    Heights (Pharmaceuticals) was founded in 2013.

  • Where is Heights (Pharmaceuticals) headquartered?

    Heights (Pharmaceuticals) is headquartered in London, United Kingdom.

  • What is the size of Heights (Pharmaceuticals)?

    Heights (Pharmaceuticals) has 94 total employees.

  • What industry is Heights (Pharmaceuticals) in?

    Heights (Pharmaceuticals)’s primary industry is Pharmaceuticals.

  • Is Heights (Pharmaceuticals) a private or public company?

    Heights (Pharmaceuticals) is a Private company.

  • What is Heights (Pharmaceuticals)’s current revenue?

    The current revenue for Heights (Pharmaceuticals) is .

  • How much funding has Heights (Pharmaceuticals) raised over time?

    Heights (Pharmaceuticals) has raised $13.8M.

  • Who are Heights (Pharmaceuticals)’s investors?

    ForGood Global, Downing Ventures, Low Carbon Innovation Fund, Spacestation Investments, and Chris Smalling are 5 of 20 investors who have invested in Heights (Pharmaceuticals).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »